Table of Contents

company-logo

Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a strategic collaboration and license agreement with ModernaTX, Inc. focusing on new genome editing system for in vivo human therapeutic applications; a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell receptor-based therapeutic products in the field of treatment, prevention, or diagnosis of human cancer; and a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop, and commercialize investigational medicines using genome editing technologies. The company was incorporated in 2016 and is based in Emeryville, California.

Metagenomi Dividend Announcement

• Metagenomi does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Metagenomi dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Metagenomi Dividend History

Metagenomi Dividend Yield

Metagenomi current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Metagenomi stock? Use our calculator to estimate your expected dividend yield:

Metagenomi Financial Ratios

P/E ratio-2.07
PEG ratio-0.02
P/B ratio0.60
ROE-44.47%
Payout ratio0.00%
Current ratio6.18
Quick ratio6.18
Cash Ratio0.55

Metagenomi Dividend FAQ

Does Metagenomi stock pay dividends?
Metagenomi does not currently pay dividends to its shareholders.
Has Metagenomi ever paid a dividend?
No, Metagenomi has no a history of paying dividends to its shareholders. Metagenomi is not known for its dividend payments.
Why doesn't Metagenomi pay dividends?
There are several potential reasons why Metagenomi would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Metagenomi ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Metagenomi has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Metagenomi a dividend aristocrat?
Metagenomi is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Metagenomi a dividend king?
Metagenomi is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Metagenomi a dividend stock?
No, Metagenomi is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Metagenomi stocks?
To buy Metagenomi you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Metagenomi stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.